Dermatology · 2013 · 66 citations · 19 references
PharmacyDermatologyPharmacotherapyAllergyDermatopathologyHypersensitivityAtopic DermatitisDrug AllergyPruritic Skin DiseasePruritus ManagementSkin IrritationTopical PreparationsAtopic Dermatitis PharmacotherapyAtopic Dermatitis TreatmentDouble-blind TrialsDrug-induced PruritusInflammatory PruritusRandomizationTopical Antipruritic TherapyTreatment With Topical Corticosteroids
<b><i>Background:</i></b> In the treatment of atopic dermatitis, pimecrolimus has high antipruritic effects. <b><i>Objective:</i></b> To investigate the efficacy of 1% pimecrolimus cream in comparison to 1% hydrocortisone cream in non-atopic prurigo nodularis (PN). <b><i>Methods:</i></b> A randomized, controlled, double-blind study with intraindividual randomization was done in 30 patients (17 females, 13 males; mean age 58.5 years) with PN. <b><i>Results:</i></b> Pruritus intensity decreased significantly (p < 0.001) on both treated sides as early as after 10 days of treatment; scratch lesions improved (p < 0.001). Quality of life as assessed by the Dermatology Life Quality Index improved significantly. However, a significant advantage of pimecrolimus over hydrocortisone was not found. <b><i>Conclusion:</i></b> The results suggest that the non-steroid pimecrolimus is an effective alternative for PN treatment.
19
N.Q. Phan, Christine Blome, Fleur Fritz et al. · Acta Dermato Venereologica · 2012 · 571 citations · Full text
Visual Analogue Scale: Evaluation of the Instrument for the Assessment of Pruritus
Adam Reich, Monika Heisig, N.Q. Phan et al. · Acta Dermato Venereologica · 2012 · 493 citations · Full text
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis
Thomas A. Luger, E.J.M. van Leent, Michael Graeber et al. · British Journal of Dermatology · 2001 · 244 citations · Full text
Medicine, Dermatology, Pharmacology +13